INSIGHTS ON DRUG DEVELOPMENT
-
Key Metrics In Antibody Drug Development
Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.
-
How The Accelerator™ Drug Development Model Enhances eNPV
Discover how an integrated CDMO and CRO model can accelerate development timelines, add up to $62.9 million in value, and help you maximize long-term pipeline success with a single, streamlined partner.
-
Navigating Complexity: Tailored Analytical & Preclinical Services
Tailored analytical and preclinical strategies identify risk early, integrate data-driven insight, and streamline formulation planning to accelerate timelines and position complex molecules for scalable, successful development.
-
Development Of A Non-Standard Protein Therapeutic
Discover how a tailored development approach transformed a complex therapeutic protein into a candidate ready for early-stage clinical trials.
-
Simplify Your Cell Culture Processes11/13/2025
Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.
-
Dosage Form Scale-Up: Balancing Speed And Efficiency In Later-Stage Development9/22/2026
Reduce development risk and improve readiness for larger trials with strategies that align formulation, manufacturing, and commercialization goals.
-
Streamlining Early Drug Development: Efficient Synthesis Of Highly Potent Compounds5/6/2026
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
Enhancing Drug Performance Through Lipid-Based Formulations For CNS Indication3/11/2026
Advance CNS-penetrant therapies by optimizing oral formulations to improve bioavailability, stabilize the API, and deliver more consistent and reliable drug exposure.
-
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions11/20/2025
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
DRUG DEVELOPMENT SOLUTIONS
-
Whether you're looking to boost performance, enhance your capabilities, or simply get consistent, high-quality results, HyClone™ peak expression medium and HyClone™ prime expression medium are the solutions for you.
-
Preconfigured protocols and custom assay workflows simplify microplate data acquisition and analysis
SoftMax® Pro Software for Windows 10 is designed to provide the simplicity, flexibility and power required for advanced data analysis. It provides ready-to-run protocols, analysis algorithms, and 21 different curve fit options.
-
By leveraging real-time data and operational efficiency, we accelerate timelines — manufacturing and releasing drug products in under seven days and reducing development cycles by up to 12 months.
-
The Most Accurate 1D and 2D NMR Predictors
From experimental design to data interpretation, ACD/Labs’ NMR predictors can significantly speed up your workflow. Use ACD/NMR Predictors to:
- Predict a complete set of 1D and 2D NMR spectra, for 1H, 13C, 15N, 19F, and 31P nuclei from a chemical structure
- Calculate chemical shifts and coupling constants in seconds
- Train the algorithms with in-house data to improve accuracy for novel chemical space
-
Explore a diverse range of HPLC and UHPLC columns from a comprehensive portfolio of analytical solutions, and learn how to select the right column for the right separation.